Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

Modified USP26 increases the amount of SMAD2. 1 / 1

| 1

➶

reach

"Overexpression of the catalytically inactive USP26 C/S mutant also enhanced the levels of p-SMAD2 whereas ectopic expression of USP26 slightly diminished the levels of phosphorylated SMAD2 (Fig XREF_FIG B)."

28381482

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...